ACORDA THERAPEUTICS INC : Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits (form 8-K)

Published: 2022-05-11 16:05:10 ET ACOR

Item 2.02Results of Operations and Financial Condition

On May 11, 2022, Acorda Therapeutics, Inc. (the "Company") issued a press release announcing its financial performance for the first quarter ended March 31, 2022, its financial condition as of March 31, 2022, and financial guidance for 2022. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K, and is incorporated by reference into this Item 2.02.

On May 11, 2022, the Company issued a press release jointly with Pharma Consulting Group, S.A. (known as Biopas Laboratories) announcing that the Company has entered into distribution and supply agreements with Biopas to commercialize Inbrija in nine countries within Latin America, including Brazil and Mexico. A copy of the press release is attached as Exhibit 99.2 to this Current Report on Form 8-K, and is incorporated by reference into this Item 8.01.

Item 9.01Financial Statements and Exhibits

--------------------------------------------------------------------------------